Literatur
Spies CM, Wiebe E, Tu J, Li A, Gaber T, Huscher D, Seibel MJ, Zhou H, Buttgereit F (2014) Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling. BMC Musculoskelet Disord 15:31
Tu J, Zhang Y, Kim S, Wiebe E, Spies CM, Buttgereit F, Cooper MS, Seibel MJ, Zhou H (2016) Transgenic disruption of glucocorticoid signaling in osteoblasts attenuates joint inflammation in collagen antibody-induced arthritis. Am J Pathol 186(5):1293–1301
Baschant U, Frappart L, Rauchhaus U, Bruns L, Reichardt HM, Kamradt T, Bräuer R, Tuckermann JP (2011) Glucocorticoid therapy of arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc Natl Acad Sci USA 108:19317–19322
Vettorazzi S, Bode C, Dejager L, Frappart L, Shelest E, Klaßen C, Tasdogan A, Reichardt HM, Libert C, Schneider M, Weih F, Uhlenhaut HN, David JP, Gräler M, Kleiman A, Tuckermann JP (2015) Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat Commun 6:7796
Hartmann K, Koenen M, Schauer S, Wittig-Blaich S, Ahmad M, Baschant U, Tuckermann JP (2016) Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev 96:409–447
Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David JP, Reichardt HM, Amling M, Schütz G, Tuckermann JP (2010) Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 11(6):517–531
Rauner M, Goettsch C, Stein N, Thiele S, Bornhaeuser M, De Bosscher K, Haegeman G, Tuckermann J, Hofbauer LC (2011) Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells. Endocrinology 152(1):103–112
Rauch A, Gossye V, Bracke D, Gevaert E, Jacques P, Van Beneden K, Vandooren B, Rauner M, Hofbauer LC, Haegeman G, Elewaut D, Tuckermann JP, De Bosscher K (2011) An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB J 25(4):1323–1332
Thiele S, Ziegler N, Tsourdi E, De Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M (2012) Selective glucocorticoid receptor modulation maintains bone mineral density in mice. J Bone Miner Res 27(11):2242–2250
Rauner M, Thiele S, Sinningen K, Winzer M, Salbach-Hirsch J, Gloe I, Peschke K, Haegeman G, Tuckermann JP, Hofbauer LC (2013) Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis. Endocrinology 154(10):3719–3728
Garbe AI, Roscher A, Schüler C, Lutter AH, Glösmann M, Bernhardt R, Chopin M, Hempel U, Hofbauer LC, Rammelt S, Egerbacher M, Erben RG, Jessberger R (2012) Regulation of bone mass and osteoclast function depend on the F‑actin modulator SWAP-70. J Bone Miner Res 27(10):2085–2096
Roscher A, Hasegawa T, Dohnke S, Ocaña-Morgner C, Amizuka N, Jessberger R, Garbe AI (2016) The F‑actin modulator SWAP-70 controls podosome patterning in osteoclasts. Bone Rep 5:214–221
Ripich T, Chacón-Martínez CA, Fischer L, Pernis A, Kiessling N, Garbe AI, Jessberger R (2016) SWEF proteins distinctly control maintenance and differentiation of hematopoietic stem cells. PLoS ONE 11(8):e161060
Braun T, Lepper J, Ruiz Heiland G, Hofstetter W, Siegrist M, Lezuo P, Gaestel M, Rumpler M, Thaler R, Klaushofer K, Distler JH, Schett G, Zwerina J (2013) Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. J Bone Miner Res 28(4):936–947
Duan Z, Horwitz M (2005) Gfi-1 takes center stage in hematopoietic stem cells. Trends Mol Med 11:49–52
Person RE, Li FQ, Duan Z, Benson KF, Wechsler J, Papadaki HA, Eliopoulos G, Kaufman C, Bertolone SJ, Nakamoto B, Papayannopoulou T, Grimes HL, Horwitz M (2003) Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 34:308–312
Karsunky H, Zeng H, Schmidt T, Zevnik B, Kluge R, Schmid KW, Duhrsen U, Moroy T (2002) Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet 30:295–300
Borzutzky A, Reyes ML, Figueroa V, Garcia C, Cavieres M (2006) Osteoporosis in children with severe congenital neutropenia: bone mineral density and treatment with bisphosphonates. J Pediatr Hematol Oncol 28:205–209
Papadaki HA, Tsatsanis C, Christoforidou A, Malliaraki N, Psyllaki M, Pontikoglou C, Miliaki M, Margioris AN, Eliopoulos GD (2004) Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis. J Bone Miner Metab 22:577–587
Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, Lell M, Manger B, Rech J, Naschberger E, Holmdahl R, Krenn V, Harrer T, Jeremic I, Bilyy R, Schett G, Hoffmann M, Herrmann M (2014) Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med 20(5):511–517
Biermann MH, Podolska MJ, Knopf J, Reinwald C, Weidner D, Maueröder C, Hahn J, Kienhöfer D, Barras A, Boukherroub R, Szunerits S, Bilyy R, Hoffmann M, Zhao Y, Schett G, Herrmann M, Munoz LE (2016) Oxidative burst-dependent NETosis is implicated in the resolution of necrosis-associated sterile inflammation. Front Immunol 7:557
Maueröder C, Kienhöfer D, Hahn J, Schauer C, Manger B, Schett G, Herrmann M, Hoffmann MH (2015) How neutrophil extracellular traps orchestrate the local immune response in gout. J Mol Med 93(7):727–734
Pieterse E, Jeremic I, Czegley C, Weidner D, Biermann MH, Veissi S, Maueröder C, Schauer C, Bilyy R, Dumych T, Hoffmann M, Munoz LE, Bengtsson AA, Schett G, van der Vlag J, Herrmann M (2016) Blood-borne phagocytes internalize urate microaggregates and prevent intravascular NETosis by urate crystals. Sci Rep 6:38229
Muñoz LE, Bilyy R, Biermann MH, Kienhöfer D, Maueröder C, Hahn J, Brauner JM, Weidner D, Chen J, Scharin-Mehlmann M, Janko C, Friedrich RP, Mielenz D, Dumych T, Lootsik MD, Schauer C, Schett G, Hoffmann M, Zhao Y, Herrmann M (2016) Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation. Proc Natl Acad Sci U S A 113(40):E5856–E5865
Liu P, Baumgart M, Groth M, Wittmann J, Jäck H‑M, Platzer M et al (2016) Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation. Sci Rep 6:32112
Förderung
Die Studien sind gefördert durch die Deutsche Forschungsgemeinschaft im Rahmen des SPP1468 „Osteoimmunology – IMMUNOBONE – A Program to Unravel the Interactions between Immune System and Bone“.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Rauner, F. Buttgereit, J. Distler, A.I. Garbe, M. Herrmann, L. Hofbauer, M. Hoffmann, R. Jessberger, U. Kornak, G. Krönke, S. Mundlos, C. Spies, J. Tuckermann und J. Zwerina geben an, dass kein Interessenkonflikt besteht.
Für diese Untersuchungen wurden sowohl Untersuchungen an Mäusen durchgeführt, als auch Proben von Patienten gesammelt. Alle Untersuchungen wurden durch die jeweiligen Ethikkommissionen der Einrichtungen sowie die Tierschutzbehörden genemigt.
Rights and permissions
About this article
Cite this article
Rauner, M., Buttgereit, F., Distler, J. et al. Osteoimmunologie – IMMUNOBONE. Z Rheumatol 77 (Suppl 1), 12–15 (2018). https://doi.org/10.1007/s00393-018-0455-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-018-0455-0